Acute bacterial skin and skin structure infections (ABSSSI) are the type of skin and soft tissue infections that affect the epidermis, dermis, and subcutaneous tissues. The U.S. FDA defines ABSSSI as lesions with cellulitis/erysipelas, wound infections, and major cutaneous abscesses occurring in a minimum surface area of 75 cm2. Pathogens such as Methicillin sensitive Staphylococcus aureus (MSSA), Methicillin resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa are the major causes of ABSSSI. This infection is difficult to treat due to increasing prevalence of drug resistant strains, especially in Staphylococcus spp. and Enterococcus spp. The ABSSSI market is expected to witness moderate growth owing to the increasing number of patients suffering from skin infections and large number of pipeline products, which are expected to receive approval during the forecast period.
Get PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/4273
North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market – Impact of Coronavirus (COVID-19) Pandemic
Acute bacterial skin and skin structure infections (ABSSSI) antibiotics treatment is required for majority of patients with severe bacterial skin infection and the treatment might be delayed due to the pandemic. Although, during the COVID-19 pandemic, the antibiotic treatment of ABSSSI patients is often postponed or even cancelled due to the unavailability of ABSSSI antibiotics and irregular supply and transportation of products. Moreover, according to a study published in the Antimicrobial Agents and Chemotherapy journal, the monthly use of antibiotic therapy from March through June 2020 decreased by 151.5% per month compared with January 2018 through February 2020 - a 6.5% monthly reduction in use of antibiotics.
The North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market is estimated to be valued at US$ 1,283.8 million in 2020 and is expected to exhibit a CAGR of 3.9% during the forecast period (2020-2027).
Increasing research and development activities are expected to boost growth of the North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market.
The major driver for the growth of the North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market is research and development of products and novel treatments by pharmaceutical and biopharmaceutical companies. For instance, in August 2019, Basilea Pharmaceutica Ltd. announced positive topline results for the phase 3 TARGET study, evaluating ceftobiprole in the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI). Ceftobiprole medocaril, is a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. This includes methicillin-susceptible and resistant Staphylococcus aureus (MSSA, MRSA) and susceptible Pseudomonas spp. Ceftobiprole is currently in phase 3 clinical development for a potential registration in the U.S., with a completed study in acute bacterial skin and skin structure infections (ABSSSI) and an ongoing study in Staphylococcus aureus bacteremia (SAB).
Furthermore, several key players in the market are focused on obtaining product approvals and launching them in the market to provide better treatment options for ABSSSI. This is expected to significantly drive growth of the North America and Europe ABSSSIs market in near future. For instance, in October 2018, Paratek Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved NUZYRA (omadacycline) for the treatment of adults with community-acquired bacterial pneumonia (CABP) and acute skin and skin structure infections (ABSSSI). NUZYRA, a modernized tetracycline, is a once-daily IV and oral antibiotic that exhibits activity across a spectrum of bacteria, including Gram-positive, Gram-negative, atypicals, and drug resistant strains.
North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market – Restraints
Patent expiration of ABSSSI antibiotic drugs is a major factor restraining growth of the North America and Europe acute bacterial skin and skin structure infections (ABSSSI) market. According to the Centers for Disease Control and Prevention, the World Health Organization, and U.S. and European governments, patent expiration leads to the production of low priced and low cost generic drugs are easily accessible which leads to their overuse and misuse. Bacteria evolve when subjected to selective pressure and multi-antibiotic resistance in organisms as ubiquitous as Escherichia coli and Staphylococcus aureus has been observed. Furthermore, patent expiry has led low cost generic drugs to dominate the market and misuse of drugs.
North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market – Regional Analysis
North America is expected to hold dominant position in the North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) market. Launch of products by key players is propelling growth of the North America acute bacterial skin and skin structure infections (ABSSSI) market. For instance, in June 2018, Melinta Therapeutics, Inc., a commercial-stage company focused on developing and commercializing novel antibiotics to treat serious bacterial infections, announced the U.S. launch of intravenous and oral formulations of Baxdela (delafloxacin) for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria.
Europe is expected to witness significant growth in the market due to increasing number of product approvals. For instance, in August 2016, Cardiome Pharma Corp. announced that XYDALBA (dalbavancin) has been approved by the European Medicines Agency (EMA) for administration as a single, 30 minute, 1500 mg infusion (three 500mg vials) as a treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in adults.
North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market - Competitive Landscape
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/4273
Key players operating in the North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) market are Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Paratek Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Arrevus, Inc., AbbVie Inc., Aurobindo Pharma Ltd., Amneal Pharmaceuticals LLC, and Sun Pharmaceutical Industries Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
The study involved four major activities for estimating the current size of the patient lateral transfer market.
The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Revenue Share Analysis, Parent Market and top-down approaches were employed to estimate the complete market size.According MarketsandMarkets Research – The Patient Lateral Transfer Market is expected to reach USD 446.2 billion by 2025 from USD 288.7 billion in 2020, at a CAGR of 9.1% during the forecast period of 2020 to 2025.COVID-19 Impact on the Patient lateral transfer Market;Coronavirus has spread across 215 countries and territories and affected more than 4.4 million people, with close to 300 thousand deaths.
Increased number of hospitalizations due the COVID-19 outbreak is anticipated to propel the market growth over the forecast period.
For instance, according to the Centers for Disease Control and Prevention (CDC), April 24, 2020, the rate of hospitalization due to COVID-19, for people of age 65 and above is 95.5 per 100,000.
Many key players in the market have observed positive impact on its revenue due to higher demand of beds and lateral transfer devices.Browse 95 market data Tables and 36 Figures spread through 148 Pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=93948116The regular air-assisted transfer mattress segment will dominate the air-assisted lateral transfer.Based on type, the air-assisted lateral transfer mattresses market has been segmented into regular, split-leg, and half mattresses.
It is an imaging technique that combines the use of light reflection to produce the image of the interior component, and generates a 2-dimensional cross-section interpretation.
It facilitates accurate and clear diagnosis of the condition.Get Research Insights @ https://www.adroitmarketresearch.com/contacts/request-sample/1403The global structural heart imaging market is mainly driven by factors such as the growing prevalence of structural heart diseases (CHDs) globally, increasing developments in imaging modality technology along with rising awareness of heart-related diseases such as high blood pressure.
According to an article published by the Centers for Disease Control and Prevention, in 2019, CHDs affect approx 1% of about 40,000 births per year and approximately 100-200 deaths occur due to unrecognized heart diseases in newborns each year in the United States.
Therefore, as a result, demand for structural heart imaging is also rising, which further contributes to the growth of the global market.
However, the main constraints for the structural heart imaging industry are high cost and limited reimbursement policies.Increasing research and clinical trials related to structural heart imaging technique boosting the growth of the marketThe growing application of angiograms in generalized imaging techniques often increases the likehood of adopting structural cardiac imaging techniques, consequently boosting demand for structural heart imaging.
In addition, rising government funding in research and clinical trials for structural heart imaging techniques accelerate the market growth.Access Complete Report @ https://www.adroitmarketresearch.com/industry-reports/structural-heart-imaging-marketEchocardiogram segment is expected to account for significant revenue share in the global marketEchocardiogram segment is dominating the global market during the forecast period owing to the low cost associated with the test as compared to CT & MRI, growing number of valvular and nonvalvular heart disease, rapid demand in transcatheter aortic valve replacement along with its superiority in the visualization of intracardiac structures accelerate the growth of echocardiogram segment.North America is expected to dominate the global marketGeographically, the global structural heart imaging market is classified into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa.
The global elastography imaging market is mainly driven by the rising incidence of breast cancer and increasing prevalence of liver disorders such as hepatitis B, and liver cancer.
In addition, as per the data published by the Centers for Disease Control and Prevention, approx 4.5 million adults were diagnosed with liver disease in 2018.Request a sample of this report @ https://www.adroitmarketresearch.com/contacts/request-sample/1398 Therefore, as a result, increasing demand for elastography imaging in terms of detecting such diseases is propelling the growth of the elastography imaging market globally.
However, high capital costs involved in medical devices concerning diagnostic purpose, and lack of supportive reimbursement system, are likely to hamper the growth of the global elastography imaging market.Elastography currently has wide application in the evaluation of thyroid, breast, liver, and prostate.
The growing number of ongoing research are likely to rise their diagnostic application of different condition such as chronic kidney disease and neurodegenerative disorders.
Besides, the elastography imaging technique is a painless method, and also offers ease in handling of the types of equipment, such factors are propelling the growth of the global elastography imaging market.
Yet the ultrasonic elastography imaging method sometimes provides inaccurate results in patients with small intercostal spaces and high obesity.
Global Antibiotics Market Research Report: By Drug class (Cephalosporins, Penicillin, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, Others), By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), By Drug Origin (Natural, Semi-synthetic, Synthetic) and By End-User (Hospitals & Clinics, Research Organizations, Others) – Forecast to 2025Market Highlights:According to MRFR analysis, Antibiotics Market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 and was valued at USD 51,835 Million in 2018.Antibiotics are powerful medicines that fight bacterial infections.
Several types of antibiotics are available, and they are generally available with a prescription in most countries.The growth of global antibiotics market is driven by various factors such as increasing efforts undertaken by major companies for the development of advanced antibiotic products, development of generic drugs, increasing approval of antibiotic drugs, rise in incidence of chronic and infectious diseases, growing investment opportunities by biotech companies in research and development, is expected to drive the growth of the global antibiotics market.Several market players currently dominate the global antibiotics market.
The carbapenem segment is likely to be the fastest growing during the review period due to the increasing incidence of pneumonia, urinary tract infections, which would increase the usage of the carbapenem class of antibiotics.
The broad-spectrum antibiotic segment is expected to hold the majority share of the market as this broad-spectrum antibiotic act against a wide range of diseases, which helps to fight against microbial resistance.The global antibiotics market has been segmented based on drug origin into natural, semisynthetic, and synthetic.
Semisynthetic is expected to be the fastest segment owing to fewer side-effects and has a higher spectrum of activity, which would eventually drive the growth of the antibiotic market in this segment.The global antibiotics market has been segmented based on drug origin into natural, synthetic, and semisynthetic.The end user segment of the antibiotics market includes hospitals & clinics, research organizations, and others.
For instance, according to centers for disease control and prevention (CDC), in 2018, use of the most antibiotics in hospitals increased by nearly 40% for carbapenems and more than 30% for vancomycin.
The growing appetite for healthy and nutrient-rich food products, across the world, is the important factor providing a prime impetus for the growth of the Health Foods Market .
It became explicit to them that healthy nutritional diets play a prominent role in impacting emotional, physical, and cognitive health, and their lack can lead to poor health and various lifestyle-related diseases such as cardiovascular disease, osteoporosis, cancer, hypertension, obesity, diabetes, nutritional anemia, and dementia.
Thus, the huge presence of urban population across the world, which can be fathomed from the statistics by the World Bank, according to which, the 55.3% of the total population lives in urban areas, as of 2018, in conjunction with the increasing awareness about the benefits of healthy food eating habits is propelling the demand in the global health foods market.The report covers Health Foods Market size by Distribution Channels and Products, Health Foods Market share by top 5 companies and also the market share by start-ups during the forecast period.View Full Table of Contents of Smart Irrigation Market:https://www.industryarc.com/Report/19030/health-foods-marketReport Price (Single User): US $3850As of 2018, the global health foods market observed a valuation of $805 billion, and the demand in the market is poised to project at a standard CAGR of 4.2% during the forecast period 2019-2025.The Growing Malnutrition Concerns Providing Impetus to the Health Foods Market Growth—The growing demand for nutritious and protein-rich food product to curb the malnutrition across the world is catapulting the growth in the health foods market.
The prevalence and universality of malnutrition are creating an alarm in every country as it causes severe health issues such as gastroenteritis, pneumonia, kwashiorkor, and measles.
According to the World Health Organization (WHO), in 2018, around 1.9 billion adults worldwide are overweight, while 462 million are underweight; wherein among the children under the age of 5 years, 41 million are overweight, 155 million are stunted, and 52 million are wasted.
This disquieting figure has instigated the people to prefer health and wellness food products such as therapeutic food, organic food, functional food and Mongolian food that prevents the incidence of diseases, alleviate illness, promote weight loss, and aid in weight and health management to achieve a state of wellness.
Remote Patient Monitoring System Market is valued at USD 1093.47 Million in 2018 and expected to reach USD 3229.13 Million by 2025 with the CAGR of 16.73% over the forecast period.Increasing incidences of cardiovascular diseases, lifestyle related disorders and demand for independent and healthy living are some of the major factors driving the growth of Global Remote Patient Monitoring System Market.Scope of Remote Patient Monitoring System Market Report-Remote patient monitoring system is a device including vital sign monitoring system, glucose meters and other portable devices which is used by patients at a remote location.
The remote patient monitoring system is most ordinarily used to reduce the progression of chronic disorders and to reinforce recovery after getting discharged from an acute care unit.
It is a type of mobile healthcare systems that enable patients to utilize ambulatory medical devices.
RPM is usually used to help patients that need chronic, post-discharge or senior care.Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/1099 Remote Patient Monitoring System Companies:Remote patient monitoring system market report covers prominent players like,Bosch, Welch Allyn, Johnson & Johnson, Honeywell, Roche, Philips Healthcare, Philips, Biotronik, Intel, Health anywhere Inc., Covidien Plc., American Telecar, OthersThe regions covered in this remote patient monitoring system market report are North America, Europe, Asia-Pacific and Rest of the World.
On the basis of country level, market of image-based cytometer is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.Global Remote Patient Monitoring System Market Segmentation:–By Product:Vital Sign Monitors, Special MonitorsBy Application:Cancer, Cardiovascular Diseases, Diabetes, Sleep Disorder, Weight management and Fitness Monitoring, Bronchitis, Infections, Virus, Dehydration, Hypertension, OthersBy End-User:Hospital Based Patients, Ambulatory Patients, Home HealthcareGlobal Remote Patient Monitoring System Market Dynamics–Increasing incidences of cardiovascular diseases, lifestyle related disorders and demand for independent and healthy living are the major factors expected to drive the growth of the global remote patient monitoring system market.
According to Centers for Disease Control and Prevention (CDC), in 2017, coronary heart disease is the most common type of heart disease, died 365,914 peoples.
